Performance evaluation of decision tree classifiers for the prediction of response to treatment of hepatitis C patients
Authors: 
AbuBakr Awad, Mahasen Mabrouk, Tahany Awad, Naglaa Zayed, Sherif Mousa, Mohamed SaeedAuthors Info & Claims
Pages 186 - 190
Abstract
This study included 2962 Egyptian patients with chronic hepatitis C virus (HCV) infection. Different decision-tree models were used to explore baseline predictors of response to Peginterferon plus Ribavirin therapy to discriminate HCV patients who are likely to respond. We have developed simple software that generates different possible combination of parameters for each model; using this software we were able to assort the decision-tree model according to the best performance, and to find the best classifier. The three models were comparable as regards to accuracy (about 69%); however REP Tree has shown fast and well performance for classification on medical data sets of increased size. Various pre-treatment decision tree algorithms have demonstrated that low level of Alpha-Fetal Protein (AFP) is associated with high response rate; and has the prospective to support clinical decisions regarding the proper selection of patients for therapy without imposing extra costs for additional examinations.
References
[1]
El-Zanaty, Fatma and Ann Way. 2009. Egypt Demographic and Health Survey 2008. Cairo, Egypt: Ministry of Health, El-Zanaty and Associates, and Macro International.
[2]
Dienstag JL., Mchutchison JG (2006) American gastroenterological association medical position statement on the management of hepatitis C: Gastroenterology, 130 (1), 225--226.
[3]
Khattab M., Ferenci P., Stephanos J. Hadziyannis, Colombo M., Manns P. Almasio L., Rafael Esteban, Ayman A. Abdo, Stephen A. Harrison9, Nazir Ibrahim, Cacoub P., Eslam M., Samuel S. Lee. Management of hepatitis C virus genotype 4: Recommendations of An International Expert Panel. Journal of Hepatology, 54(6). 1250--1262
[4]
Bellazzi, R., and Zupan, B. Predictive Data Mining in Clinical Medicine: Current Issues and Guidelines. International Journal of Medical Informatics, 77(2), 81--97.
[5]
Kurosaki M, Sakamoto N, Iwasaki M, et al. Pretreatment prediction of response to peginterferon plus ribavirintherapy in genotype 1 chronic hepatitis C using data mining analysis. J Gastroenterol 2011, 46(3), 401--409.
[6]
Khairy M, Fouad R, Mabrouk M, El-Akel W, Awad AB, Salama R, Elnegouly M, Shaker O. The impact of interleukin 28b gene polymorphism on the virological response to combined pegylated interferon and ribavirin therapy in chronic HCV genotype 4 infected egyptian patients using data mining analysis. Hepatitis Monthly, 13(7), E10509. DOI= http://dx.doi.org/10.5812/hepatmon.10509.
[7]
Ross Quinlan J. C4.5:Programs for Machine Learning. Morgan Kaufmann, San Mateo - CA, 1993.
[8]
Breiman LJH, Friedman RA, Olshen CJ, Stone CM. Classification and regression trees. Wadsworth Publishing, California, 1980.
[9]
Agrawal, Rakesh and Srikant, Ramakrishnan and others. Fast algorithms for mining association rules. Proc. 20th int. conf. very large data bases, VLDB, 1215, 487--499.
[10]
Murashima S, Tanaka M, Haramaki M, Yutani S, Nakashima Y, Harada K, Ide T, Kumashiro R, Sata M. A decrease in AFP level related to administration of interferon in patients with chronic hepatitis C and a high level of AFP. Dig Dis Sci (2006), 51, 808--812.
[11]
Tamura Y, Yamagiwa S, Aoki Y, Kurita S, Suda T, Ohkoshi S, Nomoto M, Aoyagi Y. Serum alpha-fetoprotein levels during and after interferon therapy and the development of hepatocellular carcinoma in patients with chronic hepatitis C. Dig Dis Sci (2009), 54, 2530--2537.
[12]
Mahasen Mabrouk, Wahid Doss, Naglaa Zayed, Shimaa Afify, Gamal Esmat. Impact of Serum Alpha-fetoprotein Levels on the Response to Antiviral Therapy in Egyptian Patients with Chronic Hepatitis C. J hepatogastroenterology (2013), 2(5).
Index Terms
- Performance evaluation of decision tree classifiers for the prediction of response to treatment of hepatitis C patients
Recommendations
Accurate Prediction of Response to Interferon-based Therapy in Egyptian Patients with Chronic Hepatitis C Using Machine-learning Approaches
ASONAM '12: Proceedings of the 2012 International Conference on Advances in Social Networks Analysis and Mining (ASONAM 2012)Hepatitis C virus' patients with genotypes 1 & 4 have break-even response rates to Pegylated-Interferon (Peg-IFN) and Ribavirin (RBV) treatment. Furthermore, the incompliance to the treatment because of its high cost and related unfavorable effects ...
Risk Factor Prediction for Heart Disease Using Decision Trees
ICIMMI '23: Proceedings of the 5th International Conference on Information Management & Machine IntelligenceGlobal mortality rates are high due to heart disease, it is crucial to early analyzing the risk factors of prediction and diagnosis are crucial. Decision trees are a reliable machine-learning method for this problem. Four decision tree algorithms CART (...
The antiviral drug Ribavirin effectively modulates the amyloid transformation of α-Synuclein protein
Abstractα-Synuclein (α-syn) is an intrinsically disordered protein, linked genetically and neuropathologically to Parkinson's disease where this protein aggregates within the brain. Hence, identifying compounds capable of impeding α-syn aggregation puts ...
Graphical AbstractDisplay Omitted
Highlights- Ribavirin, an antiviral agent and FDA approved drug acts as a potent amyloid modulatory agent against α-syn.
- Ribavirin interacts with the NAC domain of α-syn, attenuating the formation of mature fibrillar amyloid aggregates.
- ...
Comments
Please enable JavaScript to view thecomments powered by Disqus.Information & Contributors
Information
Published In
May 2014
459 pages
ISBN:9781631900112
- General Chair:
- Andreas Hein,
- Program Chairs:
- Susanne Boll,
- Friedrich Köhler
In-Cooperation
Publisher
ICST (Institute for Computer Sciences, Social-Informatics and Telecommunications Engineering)
Brussels, Belgium
Publication History
Published: 20 May 2014
Check for updates
Author Tags
Qualifiers
- Research-article
Conference
PervasiveHealth '14
PervasiveHealth '14: 8th International Conference on Pervasive Computing Technologies for Healthcare
May 20 - 23, 2014
Oldenburg, Germany
Acceptance Rates
Overall Acceptance Rate 55 of 116 submissions, 47%
Contributors
Other Metrics
Bibliometrics & Citations
Bibliometrics
Article Metrics
- 0Total Citations
- 113Total Downloads
- Downloads (Last 12 months)2
- Downloads (Last 6 weeks)0
Reflects downloads up to 22 Dec 2024
Other Metrics
Citations
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Sign in